Literature DB >> 21216957

EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling.

Yung-Luen Yu1, Ruey-Hwang Chou, Ling-Tzu Chen, Woei-Cherng Shyu, Su-Ching Hsieh, Chen-Shiou Wu, Hong-Jie Zeng, Su-Peng Yeh, De-Ming Yang, Shih-Chieh Hung, Mien-Chie Hung.   

Abstract

Enhancer of zeste homolog 2 (EZH2) regulates stem cells renewal, maintenance, and differentiation into different cell lineages including neuron. Changes in intracellular Ca(2+) concentration play a critical role in the differentiation of neurons. However, whether EZH2 modulates intracellular Ca(2+) signaling in regulating neuronal differentiation from human mesenchymal stem cells (hMSCs) still remains unclear. When hMSCs were treated with a Ca(2+) chelator or a PLC inhibitor to block IP(3)-mediated Ca(2+) signaling, neuronal differentiation was disrupted. EZH2 bound to the promoter region of PIP5K1C to suppress its transcription in proliferating hMSCs. Interestingly, knockdown of EZH2 enhanced the expression of PIP5K1C, which in turn increased the amount of PI(4,5)P(2), a precursor of IP(3), and resulted in increasing the intracellular Ca(2+) level, suggesting that EZH2 negatively regulates intracellular Ca(2+) through suppression of PIP5K1C. Knockdown of EZH2 also enhanced hMSCs differentiation into functional neuron both in vitro and in vivo. In contrast, knockdown of PIP5K1C significantly reduced PI(4,5)P(2) contents and intracellular Ca(2+) release in EZH2-silenced cells and resulted in the disruption of neuronal differentiation from hMSCs. Here, we provide the first evidence to demonstrate that after induction to neuronal differentiation, decreased EZH2 activates the expression of PIP5K1C to evoke intracellular Ca(2+) signaling, which leads hMSCs to differentiate into functional neuron lineage. Activation of intracellular Ca(2+) signaling by repressing or knocking down EZH2 might be a potential strategy to promote neuronal differentiation from hMSCs for application to neurological dysfunction diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21216957      PMCID: PMC3059014          DOI: 10.1074/jbc.M110.185124

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  A novel neuronal-specific splice variant of Type I phosphatidylinositol 4-phosphate 5-kinase isoform gamma.

Authors:  Maria-Luisa Giudici; Piers C Emson; Robin F Irvine
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

Review 2.  Reflections on Ca(2+)-channel diversity, 1988-1994.

Authors:  R W Tsien; D Lipscombe; D Madison; K Bley; A Fox
Journal:  Trends Neurosci       Date:  1995-02       Impact factor: 13.837

3.  Cloning of cDNAs encoding two isoforms of 68-kDa type I phosphatidylinositol-4-phosphate 5-kinase.

Authors:  H Ishihara; Y Shibasaki; N Kizuki; H Katagiri; Y Yazaki; T Asano; Y Oka
Journal:  J Biol Chem       Date:  1996-09-27       Impact factor: 5.157

4.  Spontaneous calcium influx and its roles in differentiation of spinal neurons in culture.

Authors:  J Holliday; N C Spitzer
Journal:  Dev Biol       Date:  1990-09       Impact factor: 3.582

5.  Type I phosphatidylinositol-4-phosphate 5-kinases. Cloning of the third isoform and deletion/substitution analysis of members of this novel lipid kinase family.

Authors:  H Ishihara; Y Shibasaki; N Kizuki; T Wada; Y Yazaki; T Asano; Y Oka
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

6.  Type I phosphatidylinositol-4-phosphate 5-kinases are distinct members of this novel lipid kinase family.

Authors:  J C Loijens; R A Anderson
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

7.  Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.

Authors:  Diego Pasini; Adrian P Bracken; Michael R Jensen; Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

8.  A TRPC1/TRPC3-mediated increase in store-operated calcium entry is required for differentiation of H19-7 hippocampal neuronal cells.

Authors:  Xiaoyan Wu; Tatiana K Zagranichnaya; Grzegorz T Gurda; Eva M Eves; Mitchel L Villereal
Journal:  J Biol Chem       Date:  2004-08-05       Impact factor: 5.157

9.  Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation.

Authors:  Mari Dezawa; Hiroshi Kanno; Mikio Hoshino; Hirotomi Cho; Naoya Matsumoto; Yutaka Itokazu; Nobuyoshi Tajima; Hitoshi Yamada; Hajime Sawada; Hiroto Ishikawa; Toshirou Mimura; Masaaki Kitada; Yoshihisa Suzuki; Chizuka Ide
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

10.  Tyrosine phosphorylation of type Igamma phosphatidylinositol phosphate kinase by Src regulates an integrin-talin switch.

Authors:  Kun Ling; Renee L Doughman; Vidhya V Iyer; Ari J Firestone; Shawn F Bairstow; Deane F Mosher; Michael D Schaller; Richard A Anderson
Journal:  J Cell Biol       Date:  2003-12-22       Impact factor: 10.539

View more
  28 in total

1.  The lipid kinase PIP5K1C regulates pain signaling and sensitization.

Authors:  Brittany D Wright; Lipin Loo; Sarah E Street; Anqi Ma; Bonnie Taylor-Blake; Michael A Stashko; Jian Jin; William P Janzen; Stephen V Frye; Mark J Zylka
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

2.  EZH2: a pivotal regulator in controlling cell differentiation.

Authors:  Ya-Huey Chen; Mien-Chie Hung; Long-Yuan Li
Journal:  Am J Transl Res       Date:  2012-10-10       Impact factor: 4.060

3.  Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression.

Authors:  Bin Bao; Shadan Ali; Sanjeev Banerjee; Zhiwei Wang; Farah Logna; Asfar S Azmi; Dejuan Kong; Aamir Ahmad; Yiwei Li; Subhash Padhye; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2011-11-22       Impact factor: 12.701

4.  Induction of morphological and functional differentiation of human neuroblastoma cells by miR-124.

Authors:  Samaneh Sharif; Mohammad Hossein Ghahremani; Masoud Soleimani
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

5.  The roles of EZH2 in cell lineage commitment.

Authors:  Ruey-Hwang Chou; Yung-Luen Yu; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2011-04-21       Impact factor: 4.060

6.  Genetic Association and Expression Analyses of the Phosphatidylinositol-4-Phosphate 5-Kinase (PIP5K1C) Gene in Alcohol Use Disorder-Relevance for Pain Signaling and Alcohol Use.

Authors:  Ji Soo Lee; Jill L Sorcher; Allison D Rosen; Ruslan Damadzic; Hui Sun; Melanie Schwandt; Markus Heilig; John Kelly; Kelsey L Mauro; Audrey Luo; Daniel Rosoff; Christine Muench; Jeesun Jung; Zachary A Kaminsky; Falk W Lohoff
Journal:  Alcohol Clin Exp Res       Date:  2018-05-09       Impact factor: 3.455

7.  Smurf1 regulates lung cancer cell growth and migration through interaction with and ubiquitination of PIPKIγ.

Authors:  H Li; N Xiao; Y Wang; R Wang; Y Chen; W Pan; D Liu; S Li; J Sun; K Zhang; Y Sun; X Ge
Journal:  Oncogene       Date:  2017-06-05       Impact factor: 9.867

8.  An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma.

Authors:  Jennifer M Atkinson; Anang A Shelat; Angel Montero Carcaboso; Tanya A Kranenburg; Leggy A Arnold; Nidal Boulos; Karen Wright; Robert A Johnson; Helen Poppleton; Kumarasamypet M Mohankumar; Clementine Féau; Timothy Phoenix; Paul Gibson; Liqin Zhu; Yiai Tong; Chris Eden; David W Ellison; Waldemar Priebe; Dimpy Koul; W K Alfred Yung; Amar Gajjar; Clinton F Stewart; R Kiplin Guy; Richard J Gilbertson
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

9.  Voltage-gated K+ channels in adipogenic differentiation of bone marrow-derived human mesenchymal stem cells.

Authors:  Mi-hyeon You; Min Seok Song; Seul Ki Lee; Pan Dong Ryu; So Yeong Lee; Dae-yong Kim
Journal:  Acta Pharmacol Sin       Date:  2012-12-10       Impact factor: 6.150

10.  Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer.

Authors:  Deborah L Burkhart; Katherine L Morel; Kristine M Wadosky; David P Labbé; Phillip M Galbo; Zafardjan Dalimov; Bo Xu; Massimo Loda; Leigh Ellis
Journal:  Cancer Prev Res (Phila)       Date:  2020-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.